Management and impact of obesity in Canada: A real-world survey of people with obesity and their physicians

Jennifer Glass , Sophie Carter , Esther Artime , Victoria Higgins , Lewis Harrison , Andrea Leith , David CW. Lau , Ian Patton , Jennifer L. Kuk
{"title":"Management and impact of obesity in Canada: A real-world survey of people with obesity and their physicians","authors":"Jennifer Glass ,&nbsp;Sophie Carter ,&nbsp;Esther Artime ,&nbsp;Victoria Higgins ,&nbsp;Lewis Harrison ,&nbsp;Andrea Leith ,&nbsp;David CW. Lau ,&nbsp;Ian Patton ,&nbsp;Jennifer L. Kuk","doi":"10.1016/j.obpill.2025.100171","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Obesity is a chronic relapsing disease associated with multiple complications. This study described real-world demographic/clinical characteristics, including obesity-related complications (ORCs), prescribing rationale, and patient-reported outcome measures (PROMs) for adults living with obesity in Canada accessing treatment.</div></div><div><h3>Methods</h3><div>This was a cross-sectional survey of physicians and consulting people with obesity (PwO) in Canada with retrospective data capture in a real-world setting. Canadian data were drawn between July and November 2022 from the multinational Adelphi Real World Obesity Disease Specific Programme™. Consulting PwO were required to be on a weight management program and/or have a current body mass index of ≥30 kg/m<sup>2</sup>. Physicians completed questionnaires for the next 3–5 consecutive PwO seen in their routine clinical practice. A quota was applied for obesity management medication (OMM). PROMs including Work Productivity and Activity Impairment (WPAI) questionnaire were provided voluntarily by PwO. Analyses were descriptive.</div></div><div><h3>Results</h3><div>Overall, 50 physicians (35 general practitioners, 15 endocrinologists) and 199 PwO were analyzed. More than 85 % of PwO had ≥1 ORC. The most common ORCs were hypertension, dyslipidemia, depression, and type 2 diabetes, and one-quarter to one-half of ORCs were not optimally controlled. Approximately two-thirds of the cohort were employed full-time, almost half had private insurance, and almost 70 % were classified as high socio-economic status. Mean number of weight-reduction attempts over the past 3 years was 2.9. Pharmacological treatment for obesity was common among those with ORCs. A general trend towards greater work impairment among people with ORCs than for PwO without ORCs was observed.</div></div><div><h3>Conclusions</h3><div>Among PwO participating in our study, ORCs were common, often uncontrolled, and their presence impacted the likelihood of obesity treatment and possibly impaired work productivity. Medical treatment for obesity was often delayed until ORCs developed, suggesting that preventative healthcare measures are not the norm for PwO in Canada. A large proportion of PwO had high socioeconomic status, suggesting that PwO who access treatment may not be representative of the overall population of PwO in Canada.</div></div>","PeriodicalId":100977,"journal":{"name":"Obesity Pillars","volume":"14 ","pages":"Article 100171"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Pillars","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667368125000154","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Obesity is a chronic relapsing disease associated with multiple complications. This study described real-world demographic/clinical characteristics, including obesity-related complications (ORCs), prescribing rationale, and patient-reported outcome measures (PROMs) for adults living with obesity in Canada accessing treatment.

Methods

This was a cross-sectional survey of physicians and consulting people with obesity (PwO) in Canada with retrospective data capture in a real-world setting. Canadian data were drawn between July and November 2022 from the multinational Adelphi Real World Obesity Disease Specific Programme™. Consulting PwO were required to be on a weight management program and/or have a current body mass index of ≥30 kg/m2. Physicians completed questionnaires for the next 3–5 consecutive PwO seen in their routine clinical practice. A quota was applied for obesity management medication (OMM). PROMs including Work Productivity and Activity Impairment (WPAI) questionnaire were provided voluntarily by PwO. Analyses were descriptive.

Results

Overall, 50 physicians (35 general practitioners, 15 endocrinologists) and 199 PwO were analyzed. More than 85 % of PwO had ≥1 ORC. The most common ORCs were hypertension, dyslipidemia, depression, and type 2 diabetes, and one-quarter to one-half of ORCs were not optimally controlled. Approximately two-thirds of the cohort were employed full-time, almost half had private insurance, and almost 70 % were classified as high socio-economic status. Mean number of weight-reduction attempts over the past 3 years was 2.9. Pharmacological treatment for obesity was common among those with ORCs. A general trend towards greater work impairment among people with ORCs than for PwO without ORCs was observed.

Conclusions

Among PwO participating in our study, ORCs were common, often uncontrolled, and their presence impacted the likelihood of obesity treatment and possibly impaired work productivity. Medical treatment for obesity was often delayed until ORCs developed, suggesting that preventative healthcare measures are not the norm for PwO in Canada. A large proportion of PwO had high socioeconomic status, suggesting that PwO who access treatment may not be representative of the overall population of PwO in Canada.

Abstract Image

加拿大肥胖的管理和影响:对肥胖患者及其医生的真实调查
背景:肥胖是一种伴有多种并发症的慢性复发性疾病。本研究描述了现实世界的人口统计学/临床特征,包括肥胖相关并发症(ORCs)、处方依据和患者报告的结果测量(PROMs),用于加拿大成年肥胖患者获得治疗。方法:这是一项横断面调查,调查对象是加拿大的医生和咨询肥胖患者(pvo),并在现实世界中收集回顾性数据。加拿大的数据是在2022年7月至11月期间从跨国公司阿德尔菲真实世界肥胖疾病特定计划™中提取的。咨询pw需要进行体重管理计划和/或当前体重指数≥30 kg/m2。医生在接下来的3-5个连续的临床实践中完成了问卷调查。对肥胖管理药物(OMM)实行配额。工作效率和活动障碍(WPAI)问卷由pvo自愿提供。分析是描述性的。结果共分析50名内科医生(全科医生35名,内分泌科医生15名)和199名PwO。85%以上的pvo患者ORC≥1。最常见的orc是高血压、血脂异常、抑郁症和2型糖尿病,四分之一到一半的orc没有得到最佳控制。大约三分之二的人有全职工作,几乎一半的人有私人保险,几乎70%的人被列为高社会经济地位。过去3年的平均减肥次数为2.9次。肥胖的药物治疗在ORCs患者中很常见。观察到有ORCs的人比没有ORCs的PwO有更大的工作障碍的总体趋势。在参与我们研究的pvo中,ORCs很常见,通常不受控制,它们的存在影响了肥胖治疗的可能性,并可能损害工作效率。肥胖的医疗治疗往往被推迟到ORCs发展,这表明预防性保健措施不是加拿大ppo的标准。很大一部分残疾妇女具有较高的社会经济地位,这表明获得治疗的残疾妇女可能不能代表加拿大残疾妇女的总体人口。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信